@article{6778aa4f7e644baebe56c51ac1c89235,
title = "Psychedelic-Assisted Therapy for People with Eating Disorders",
abstract = "Purpose of Review: A growing body of research suggests psychedelic-assisted therapy (PAT) may be safe and effective for a variety of mental health conditions. Among these, eating disorders have been a recent target of interest. This review provides an up-to-date summary of the potential mechanisms and use of PAT in people diagnosed with eating disorders, with a focus on anorexia nervosa. Recent Findings: Classic psychedelics may have transdiagnostic efficacy through several mechanisms relevant to eating disorder pathology. Interest in, and efforts to increase access to PAT are both high. Early clinical trials are focused on establishing the safety and utility of this treatment in eating disorders, and efficacy remains unclear. Summary: High-quality published data to support the use of PAT for people with eating disorders remains lacking. Recent studies however suggest PAT has the potential to augment the efficacy of current interventions for these difficult-to-treat conditions.",
keywords = "Anorexia nervosa, Eating disorders, Hallucinogens, Psilocybin, Psychedelics, Serotonin",
author = "Natalie Gukasyan and Schreyer, \{Colleen C.\} and Griffiths, \{Roland R.\} and Guarda, \{Angela S.\}",
note = "Funding Information: Natalie Gukasyan: All support for the present manuscript (e.g., funding, provision of study materials, medical writing, article processing charges, etc.): The Steven and Alexandra Cohen Foundation, Tim Ferriss, Matt Mullenweg, Craig Nerenberg, and Blake Mycoskie. Grants or contracts from any entity: Usona Institute. Payment or honoraria for lectures, presentations, speakers{\textquoteright} bureaus, manuscript writing or educational events: Psychedemia Conference and NYU Psychedelic Medicine CME event. Support for attending meetings and/or travel: Horizons 2022. Colleen C. Schreyer: All support for the present manuscript (e.g., funding, provision of study materials, medical writing, article processing charges, etc.): Grant Funding: The Johns Hopkins Center for Psychedelic \& Consciousness Research, 5\% FTE. Roland R. Griffiths: All support for the present manuscript (e.g., funding, provision of study materials, medical writing, article processing charges, etc.): Support from the Johns Hopkins Center for Psychedelic and Consciousness Research. Grants or contracts from any entity: PI on Usona psilocybin depression study; PI on NIDA grant focused on caffeine research; PI on sponsored and grant support for the Johns Hopkins Center for Psychedelic and Consciousness Research with funding provided by Tim Ferriss, Matt Mullenweg, Craig Nerenberg, Blake Mycoskie, and the Steven and Alexandra Cohen Foundation; and PI on psychedelic research sponsored by the Riverstyx Foundation, the Heffter Research Institute, the Turnbull family foundation, the Council on Spiritual Practices, and the Y.C. Ho/Helen and Michael Chiang Foundation. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Honoraria for presentations from University of California San Diego, Yale University, Manatt Phelps and Phillips, University of Rochester, Harvard University, Institute for Functional Medicine, Sheppard Pratt Health System, Innovations Consulting Group, Centre for Addiction and Mental Health. Support for attending meetings and/or travel: Heffter Research Institute Board meeting. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Director Johns Hopkins Center for Psychedelic and Consciousness Research and Member of Board of Directors of Heffter Research Foundation. Angela S. Guarda: All support for the present manuscript (e.g., funding, provision of study materials, medical writing, article processing charges, etc.): Grant Funding: The Johns Hopkins Center for Psychedelic \& Consciousness Research, 5\% FTE. Funding Information: Effort for all authors was provided by support from Tim Ferriss, Matt Mullenweg, Craig Nerenberg, Blake Mycoskie, and the Steven and Alexandra Cohen Foundation. Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2022",
month = dec,
doi = "10.1007/s11920-022-01394-5",
language = "English (US)",
volume = "24",
pages = "767--775",
journal = "Current psychiatry reports",
issn = "1523-3812",
publisher = "Springer",
number = "12",
}